From: Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
 | RFS | MFS | OS | ||||||
---|---|---|---|---|---|---|---|---|---|
 | HR | 95%CI | p-value | HR | 95%CI | p-value | HR | 95%CI | p-value |
Male | 4.9 × 108 | / | 0.998 | 0.78 | 0.33–1.84 | 0.573 | 0.67 | 0.24–1.86 | 0.447 |
Age ≥ 60 | 0.59 | 0.13–2.65 | 0.495 | 1.45 | 0.58–3.61 | 0.423 | 3.32 | 0.09–11.7 | 0.063 |
Size ≥ 10 cm | 0.84 | 0.18–3.78 | 0.828 | 0.98 | 0.41–2.31 | 0.965 | 1.66 | 0.59–4.67 | 0.335 |
Superficial | 0.25 | 0.03–2.11 | 0.204 | 0.88 | 0.35–2.18 | 0.787 | 1.11 | 0.39–3.15 | 0.830 |
Trunk | 2.49 | 0.55–11.2 | 0.233 | 1.71 | 0.72–4.05 | 0.218 | 2.09 | 0.75–5.81 | 0.154 |
DD | 1.11 | 0.77–1.59 | 0.562 | 1.26 | 1.07–1.50 | 0.0061 | 1.33 | 1.11–1.58 | 0.0014 |
PIC | 1.26 | 0.60–2.65 | 0.534 | 2.39 | 1.59–3.58 | 0.00003 | 1.99 | 1.42–2.79 | 0.00006 |
SF | 1.02 | 0.98–1.07 | 0.219 | 1.02 | 0.99–1.04 | 0.096 | 1.02 | 1.01–1.05 | 0.026 |
TAT | 0.95 | 0.71–1.27 | 0.736 | 0.98 | 0.89–1.09 | 0.829 | 1.01 | 0.92–1.10 | 0.855 |
High grade | 0.025 | 0.0-16.2 | 0.264 | 39.3 | 0.79–1957 | 0.065 | 67.2 | 0.76–51.3 | 0.087 |
Stage I, II vs. III, IV | 6.20 | 1.19-32.1- | 0.029 | 3.34 | 1.40–7.96 | 0.007 | 5.66 | 1.98–16.1 | 0.0011 |